VistaGen Therapeutics Aktie
WKN DE: A2AJU8 / ISIN: US92840H2022
|
01.12.2025 15:11:43
|
Vistagen Names Nick Tressler CFO
(RTTNews) - South San Francisco-based late clinical-stage biopharma company Vistagen Therapeutics, Inc. (VTGN) Monday announced the appointment of Nick Tressler as Chief Financial Officer.
Tressler has been serving as CFO of Dynex Technologies. He has more than 20 years of experience in the life sciences industry.
Further, Vistagen said its board granted Tressler an incentive option to purchase up to an aggregate of 150,000 shares of its common stock.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu VistaGen Therapeutics Incmehr Nachrichten
| Keine Nachrichten verfügbar. |